Journals / Journal of Basic and Clinical Health Sciences / 2020 / Cilt: 4 - Sayı: 1

Genetic Evaluation of Turkish patients with Colorectal Carcinoma in Terms of Lynch Syndrome by Targeted Next Generation Sequencing

Pages
59–63
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

If there is an indication for LS after genetic counseling, germline testing for definitive diagnosis of LS should be performed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose:Lynch syndrome (LS) is a hereditary cancer disorder characterized by increased lifetime risk for various cancers.
📊
Key Findings & Data:Patients and Methods:A total of 28 patients with CRC were evaluated for LS between 2016 and 2017 years.
💡
Conclusion & Impact:If there is an indication for LS after genetic counseling, germline testing for definitive diagnosis of LS should be performed.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose:Lynch syndrome (LS) is a hereditary cancer disorder characterized by increased lifetime risk for various cancers. Colorectal cancer (CRC) is the most common cancer in LS. Germline testing of mismatch repair (MMR) genes is required for definitive diagnosis of LS. The purposes of this study was to report the results of the mutation analysis of MMR genes using targeted next generation sequencing (NGS) in patients with CRC for providing benefits to the diagnosing and management of LS as the first study from Turkey, to our knowledge. Patients and Methods:A total of 28 patients with CRC were evaluated for LS between 2016 and 2017 years. Sequencing analysis by using NGS was performed in MLH1, MSH2, and MSH6 genes and deletion/duplication analysis by using multiplex ligation-dependent probe amplification (MLPA) method were performed in MLH1, MSH2, MSH6, EPCAM genes in 28 patients. Results:A total of 9 variants were found in 28 patients (4 in MSH2, 4 in MLH1, 1 in MSH6). The diagnosis of LS was confirmed in 9 patients (32%; 9/28). Four variants were assessed as known variants, 5 variants as novel. Conclusion:The patients with CRC should be evaluated in terms of LS because of increased lifetime risk of developing various cancers. If there is an indication for LS after genetic counseling, germline testing for definitive diagnosis of LS should be performed.

🔖

Cite This Article

ÖZDEMİR, T. R., DEĞİRMENCİ, M. (2022). Genetic Evaluation of Turkish patients with Colorectal Carcinoma in Terms of Lynch Syndrome by Targeted Next Generation Sequencing. Journal of Basic and Clinical Health Sciences, Cilt: 4 - Sayı: 1, 59–63. https://ajindex.com/articles/560579

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Moreira L, Balaguer F, Lindor N, et al. Identification of Lynch syndrome among patients with colorectal cancer. JAMA 2012
  2. 1555–1565. [CrossRef ] 2. Hampel H, Bennett RL, Buchanan A, Pearlman R, Wiesner GL
  3. for a Guideline Development Group of the American College of Medical Genetics and Genomics Professional Practice and Guidelines Committee and of the National Society of Genetic Counselors Practice Guidelines Committee. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Genet Med 2015
  4. 70–87. [CrossRef ] 3. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Colorectal Cancer Screening. Version 2
  5. http://www.nccn.org/professionals/physician_gls/PDF/colorectal_screening.pdf 4. Giardiello FM, Allen JI, Axilbund JE, et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer. Am J Gastroenterol 2014
  6. 1159–1179. [CrossRef ] 5. Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol 2015
  7. 223–262. [CrossRef ] 6. Herzig DO, Buie WD, Weiser MR, et al. Clinical Practice Guidelines for the Surgical Treatment of Patients With Lynch Syndrome. Dis Colon Rectum 2017
  8. 137–143. [CrossRef ] 7. Kastrinos F, Uno H, Ukaegbu C, et al. Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome. J Clin Oncol 2017
  9. 2165–2172. [CrossRef ] 8. Robinson JT, Thorvaldsdóttir H, Winckler W, et al. Integrative Genomics Viewer. Nat Biotechnol 2011
  10. 24–26. [CrossRef ] 9. Thorvaldsdóttir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 2013
  11. 178–192. [CrossRef ] 10. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015
  12. 405–423. [CrossRef ] 11. Thompson BA, Spurdle AB, Plazzer JP, et al. Application of a five-tiered scheme for standardized classification of 2, 360 unique mismatch repair gene variants lodged on the InSiGHT locus-specific databas